By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Contract research organization Apredica announced today that it has acquired the intellectual property and related assets of Cellumen for an undisclosed sum.

The acquisition provides Apredica with Cellumen's Cellular Systems Biology and high-content toxicology services and technologies. Specifically, Watertown, Mass.-based Apredica said that the deal will "significantly strengthen" the firm's high-content toxicology offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.